Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males

NCT01209325 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

149

Enrollment

NETWORK

Sponsor class

Conditions

Anal Cancer
Nonneoplastic Condition
Penile Cancer
Precancerous Condition

Interventions

BIOLOGICAL: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine
OTHER: laboratory biomarker analysis

Sponsor

AIDS Malignancy Consortium

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]